Colchicine as an oral corticosteroid sparing agent for asthma

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2003, Pages

  Dewey, Ann ^a   Bara, Anna ^b   Lasserson, Toby J ^c   Walters, E Haydn ^d  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b Medical Unit   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 12144285181     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003273     Document Type: Review

References (19)

1. Adalioglu G, Turktas I, Saraclar Y, Tuncer A, Adalioglu G, Turktas I, et al. A clinical study of colchicine in childhood asthma. Journal of Asthma 1994;31(5):361-6.
2. Bel E, Barnes N. Other pharmacotherapy. European Respiratory Review 2000;10:82-7.
3. Fish JE, Peters SP, Chambers CV, McGeady SJ, Epstein KR, Boushey HA, et al. An evaluation of colchicine as an alternative to inhaled corticosteroids in moderate asthma. American Journal of Respiratory and Critical Care Medicine 1997;156:1165-71.
4. Hill JM, Tattersfield AE. Corticosteroid Sparing Agents in Asthma. Thorax 1995;50:577-82.
5. Ilfeld DN, Mazar A, Garty M, Fink G, Spitzer S, Pecht M, et al. Effect of oral colchicine on T cell subsets, monocytes and concanavalin A-induced suppressor cell function in asthmatic patients. Clinical Allergy 1986;16(5):407-16.
6. Kelly SJ, Uri AJ, Freeland HS, Woods EJ, Schulman ES, Peters SP, et al. Effects of colchicine on IgE-Mediated Early and Late Airways Reactions. Chest 1995;107:985-91.
7. Lynch JP, McCune WJ. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. American Journal of Respiratory & Critical Care Medicine 1997;155(2):394-420.
8. Moss RB. Alternative pharmacotherapies for steroid-dependent asthma. Chest 1995;107(3):817-25.
9. Newman KB, Mason UG, Buchmeier A, Schmaling KB, Corsello P, Nelson HS. Failure of colchicine to reduce inhaled triamcinolone dose in patients with asthma. Journal of Allergy Clinical Immunology 1997;99(2):176-8.
10. Schwarz YA, Kivity S, Ilfeld DN, Schlesinger M, Greif J, Topilsky M, et al. A clinical and immunologic study of colchicine in asthma. Journal of Allergy and Clinical Immunology 1990;85(3):578-82.
11. Szefler SJ. Anti-inflamatory drugs in the treatment of allergic disease. Medical Clinics of North America 1992;76(4):953-75.
12. Turktas I, Adalioglu G, Saraclar Y, Tuncer A. A clinical study of colchicine in childhood asthma. Gazi Tip Dergisi 1993;4(4):185-9.
13. Wenzel SE. New approaches to anti-inflammatory therapy for asthma. The American Journal of Medicine 1998;104:287-300.
14. Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW. Beclomethasone versus placebo for chronic asthma (Cochrane Review). Cochrane Database of Systematic Reviews 2005, Issue 1. [Art. No.: CD002738. DOI: 10.1002/14651858.CD002738.pub2.]
15. Adams NP, Bestall JC, Lasserson TJ, Jones PW, Cates CJ. Fluticasone versus placebo for chronic asthma in adults and children (Cochrane Review). Cochrane Database of Systematic Reviews 2005, Issue 4. [Art. No.: CD003135. DOI: 10.1002/14651858.CD003135.pub3.]
16. Barnes PJ. Molecular mechanisms of steroid action in asthma. Journal of Allergy and Clinicial Immunology 1996;97:168-79.
17. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial Mediterranean fever: a double-blind trial. New England Journal of Medicine 1974;291:934-7.
18. Ilfeld D, Kivity S, Feierman E, Topilski M, Kuperman O. Effect of in vitro colchicine and oral theophylline on suppressor cell function of asthmatic patients. Clinical and Experimental Immunology 1985;61:360-7.
19. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.